Abstract
Medical artificial general intelligence (AGI) is an emerging field that aims to develop systems specifically designed for medical applications that possess the ability to understand, learn, and apply knowledge across a wide range of tasks and domains. Large language models (LLMs) represent a significant step towards AGI. However, training cross-domain LLMs in the medical field poses significant challenges primarily attributed to the requirement of collecting data from diverse domains. This task becomes particularly difficult due to privacy restrictions and the scarcity of publicly available medical datasets. Here, we propose Medical AGI (MedAGI), a paradigm to unify domain-specific medical LLMs with the lowest cost, and suggest a possible path to achieve medical AGI. With an increasing number of domain-specific professional multimodal LLMs in the medical field being developed, MedAGI is designed to automatically select appropriate medical models by analyzing users’ questions with our novel adaptive expert selection algorithm. It offers a unified approach to existing LLMs in the medical field, eliminating the need for retraining regardless of the introduction of new models. This characteristic renders it a future-proof solution in the dynamically advancing medical domain. To showcase the resilience of MedAGI, we conducted an evaluation across three distinct medical domains: dermatology diagnosis, X-ray diagnosis, and analysis of pathology pictures. The results demonstrated that MedAGI exhibited remarkable versatility and scalability, delivering exceptional performance across diverse domains. Our code is publicly available to facilitate further research at https://github.com/JoshuaChou2018/MedAGI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Juexiao Zhou, Xiuying Chen, and Xin Gao were supported in part by grants from the Office of Research Administration (ORA) at King Abdullah University of Science and Technology (KAUST) under award number FCC/1/1976-44-01, FCC/1/1976-45-01, REI/1/5202-01-01, REI/1/5234-01-01, REI/1/4940-01-01, RGC/3/4816-01-01, and REI/1/0018-01-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of King Abdullah University of Science and Technology (KAUST) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data for pathology can be accessed at https://github.com/masatsuneki/ histopathology-image-caption. The data for XrayChat can be accessed at https://github.com/UCSD-AI4H/xraychat. The SKINCON dataset can be accessed at https://skincon-dataset.github.io/. The Dermnet dataset can be accessed at https://www.kaggle.com/datasets/ shubhamgoel27/dermnet. The restricted in-house skin disease images of SkinGPT-4 are not publicly available due to restrictions in the data-sharing agreement.
